A stratified two-stage tumor molecular profiling algorithm to identify clinically actionable molecular alterations in pancreatic cancer☆
Background: Tumor molecular profiling (TMP) for pancreatic cancer (PC) is recommended by current international guidelines, yet no testing standards exist. Moreover, the magnitude of benefit and the cost-effectiveness of comprehensive next-generation sequencing panels for PC are under debate. Materia...
Saved in:
Main Authors: | S. Hussung, D. Akhoundova, C. Pistoni, D. Lenggenhager, A. Töpfer, C. Pauli, B. Pestalozzi, C. Britschgi, M. Zoche, M. Rechsteiner, H. Moch, A. Weber, R. Fritsch |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | ESMO Gastrointestinal Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2949819825000032 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Empowering personalized oncology: evolution of digital support and visualization tools for molecular tumor boards
by: Cosima Strantz, et al.
Published: (2025-01-01) -
Exploiting somatic oncogenic driver alterations in a patient with Li-Fraumeni syndrome– paving the path towards precision medicine: a case report
by: Carolin Seeling, et al.
Published: (2025-01-01) -
Expert Consensus on Molecular Tumor Boards in Taiwan: Joint Position Paper by the Taiwan Oncology Society and the Taiwan Society of Pathology
by: Ming-Huang Chen, et al.
Published: (2024-01-01) -
Clinical integration of germline findings from a tumor testing precision medicine program
by: Maria Carolina Sanabria-Salas, et al.
Published: (2025-01-01) -
Relevance of tumor boards for the inclusion of patients in oncological clinical trials
by: Hendrik Dapper, et al.
Published: (2023-03-01)